Adaptive Biotechnologies Corp. (ADPT)
14.69
+0.26
(+1.80%)
USD |
NASDAQ |
May 07, 16:00
14.49
-0.20
(-1.36%)
Pre-Market: 08:25
Adaptive Biotechnologies SG&A Expense (TTM) : 126.83M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Thermo Fisher Scientific, Inc. | 8.46B |
| Sotera Health Co. | 189.70M |
| FONAR Corp. | 30.72M |
| Interpace Biosciences, Inc. | 19.40M |
| XWELL, Inc. | 16.00M |